Floatz logo

Vinorelbine

Metastatic Malignant Solid Neoplasm

OHSU Knight Cancer InstitutePhase 1/2Active
CCC
51/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
44/ 100
Competitive Position
73/ 100

Competitive context

74 Active assets in the Metastatic Malignant Solid Neoplasm cohort.

Asset / SponsorPhaseRating
Ipilimumab
Federation Francophone de Cancerologie Digestive
Phase 3BB
Nivolumab
Fred Hutchinson Cancer Center
Phase 3BB
Abemaciclib
National Cancer Institute (NCI)
Phase 3B
Carboplatin
Revolution Medicines, Inc.
Phase 2B
TEONANACATL
University of Washington
Phase 2B

View all 50 →

Same molecule, other indications

Vinorelbine is also rated in:

HER2 positive breast carcinomaDormant
BBB
Indicative ·
74 / 100
View asset →
Recurrent Breast CarcinomaDormant
BBB
Indicative ·
72 / 100
View asset →
Hodgkins lymphomaDormant
BBB
Indicative ·
72 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →